During our session on biotech financing, I would like to give a glimpse into the life of a biotech company. Financing is the most prominent topic for every CEO: how to raise funds, when, how much and from which source and???
We’ll discuss different financing options and highlight the inherent challenges depending on the stage of your company. Further we’ll touch upon some of the do’s and don’ts, introduce the most important VC lingo and give some insights into the way VCs think and act.
Christina Takke is co-founder and Managing Director of V-Bio Ventures. Christina has more than 15 years of investment experience in European Venture Capital. Before setting up V-Bio Ventures, Christina was a partner at Forbion Capital Partners (previously ABN AMRO Capital) were she led and managed a series of successful investments in biopharmaceutical and pharmaceutical companies. She holds a PhD in Developmental Biology, which she obtained under the supervision of Prof. Dr. Campos-Ortega at the Institute of Development Biology at the University of Cologne, Germany. After her studies, she worked with biotech start-up companies at Bio-gen-tec-NRW in Cologne, a regional development organization for the biotechnology industry. In this position, she evaluated business proposals and assisted the young biotech companies in the fundraising process. She currently serves on the supervisory boards of Confo Therapeutics, Octimet, Oxular Ltd and Syndesi Therapeutics.